Oppenheimer & Co’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Oppenheimer & Co's BCAT Position: Q2 2026 in Review
Oppenheimer & Co reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 2.1% in Q2 2026, selling an estimated $6.3K and leaving 19,554 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #1461.
Oppenheimer & Co first reported a position in BCAT in Q3 2021 and has held it in 20 quarters since. The position peaked at $942K in Q3 2024. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Oppenheimer & Co held 19,554 shares of BlackRock Capital Allocation Term Trust worth $311K as of Q2 2026.
- Oppenheimer & Co sold 410 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $6.3K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1461 holding.
- Oppenheimer & Co first reported a position in BlackRock Capital Allocation Term Trust in Q3 2021 and has held it in 20 quarters since.
- Oppenheimer & Co's BlackRock Capital Allocation Term Trust position peaked at $942K in Q3 2024.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.